- Co-amoxiclav
drugbox
type = combo
component1 = Amoxicillin
class1 = Penicillin antibiotic
component2 = Potassium clavulanate
class2 =Beta-lactamase inhibitor
CAS_number = 74469-00-4
ATC_prefix = J01
ATC_suffix = CR02
PubChem = 6435924
DrugBank =
pregnancy_AU =
pregnancy_US = B
pregnancy_category =
legal_AU =
legal_CA =
legal_UK = POM
legal_US =
legal_status =
routes_of_administration = oral, ivCo-amoxiclav is the
British Approved Name , in theBritish Pharmacopoeia , for the combination antibiotic containing amoxicillin trihydrate a β-lactam antibiotic with clavulanate potassium a β-lactamase inhibitor. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against β-lactamase producing amoxicillin-resistant bacteria.This name, unlike
co-trimoxazole , has not been widely adopted internationally and the combination product is usually referred to by various names such as amoxicillin with clavulanic acid or amoxicillin+clavulanate or simply by a trade name such as CLAMP (228.5mg, 457mg & 625mg)(FGP), Augmentin (byGlaxoSmithKline formerly Beecham)cite book |title=British National Formulary |edition=54 |date=Septemember 2007] , and Exclav (byNeomed ) Clavamox (forveterinary use byPfizer ), or Clavamel.History
Co-amoxiclav was invented around 1977/78 by British scientists working at Beecham, which filed for US patent protection for the drug combination in 1979. U.S. Patents 4,441,609 was granted in 1984.
Dosage
The proportions of the two constituents are expressed as "x"/"y" where "x" and "y" are the strengths in milligrams of amoxicillin and clavulanic acid respectively. However, the branded products indicate their strengths as the quantity of amoxicillin, hence co-amoxiclav 250/125 ≡ Augmentin 250 and contains 250 mg of amoxicillin with 125 mg of clavulanic acid.cite web |title=Augmentin -- Prescribing Information |url=http://us.gsk.com/products/assets/us_augmentin.pdf |format=PDF |month=December | year=2006 |publisher=GlaxoSmithKline |accessdate=2008-01-28]
Standard adult dosages for respiratory tract, urinary, abdominal and dental infections as well as cellulitis and animal bites is co-amoxiclav 250/125 (one tablet Augmentin 250) taken every 8 hours, which may be doubled in severe infections (as a single tablet of co-amoxiclav 500/125 ≡ Augmentin 500, but not as two co-amoxiclav 250/125 tablets which would double the maximum recommended dose of clavulanic acid). In the US, Augmentin XR (co-amoxiclav 1000/62.5) is marketed for use in community acquired pneumonia with two tablets taken twice a day (giving 4000 mg total daily dose of amoxicillin).
Dosages for children are also given three times a day using suspensions containing co-amoxiclav 250/62 in each 5 mL (Augmentin '250/62 SF') for those between the ages of 6–12 years and co-amoxiclav 125/31 (Augmentin '125/31 SF') for those between the ages of 1–6 years. A more concentrated solution, co-amoxiclav 400/57 (Augmentin '400/57 SF'), may be administered more conveniently just twice daily to children from as young as 2 months of age; quantities are based on body weight with 2.5 mL from the age of 2 years and 5 mL after the age of 6 years.
Wikimedia Foundation. 2010.